However, results from clinical studies have so far provided contrasting results, with these findings indicating a debatable role of PTX3 as related to active mediation of endothelial dysfunction, atherosclerotic plaque vulnerability, and worsened outcomes after ischemic events (Katakami et al., 2013). This evidence concerns the gene PTX3 and endothelial dysfunction.